InsiderTrades

Form 4 for NUTX Nutex Health Inc.

Accepted 2024-03-14 00:00:00 ET · period of report 2024-03-12 · accession 0001486189-24-000019 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-03-14 2024-03-12 NUTX Montgomery Pamela W. CLO M - OptEx $0.00 +16.5K 45.0K +58% $0
D 2024-03-14 2024-03-12 NUTX Montgomery Pamela W. CLO M - OptEx $0.00 -16.5K 16.5K -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-03-12 M A 16,502 $0.00 45,004 D — — (F2) Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.
2 Derivative Restricted Stock Units 2024-03-12 M D 16,502 $0.00 16,501 D — · — to — 16,502 Common Stock (F2) Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. (F3) Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Ms. Montgomery, dated April 1, 2023, the 49,505 RSUs granted to Ms. Montgomery will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025.